临床儿科杂志 ›› 2019, Vol. 37 ›› Issue (8): 616-.doi: 10.3969/j.issn.1000-3606.2019.08.015

• 综合报道 • 上一篇    下一篇

PRRT2基因突变相关发作性疾病临床特征及突变分析

周昀箐 1, 贺影忠 1, 王翠锦 1, 王英燕 1, 韩凤 1, 姚如恩 2, 王剑 2, 陈莹 1, 王纪文 1   

  1. 国家儿童医学中心, 上海交通大学医学院附属上海儿童医学中心, 1.神经内科,2.分子诊断中心 (上海 200127)
  • 发布日期:2019-08-09
  • 通讯作者: 王纪文 电子信箱:wangjiwen@scmc.com.cn
  • 基金资助:
    上海市级医院新兴前沿技术项目(No.SHDC 12015113)

Clinical characteristics and genetic features analysis of PRRT2-associated paroxysmal diseases

 ZHOU Yunqing1,HE Yingzhong1,WANG Cuijin1,WANG Yingyan1,HAN Feng1,YAO Ruen2,WANG Jian2,CHEN Ying1,WANG Jiwen1   

  1. 1.Department of Neurology, 2.Department of Laboratory Medicine, Shanghai Children’s Medical Center Affiliated to Shanghai Jiao Tong University School of Medicine, National Children’s Medical Center, Shanghai 200127, China
  • Published:2019-08-09

摘要: 目的 分析PRRT2基因突变相关发作性疾病患儿基因型与表型的关联。方法 回顾分析2016年5月至2018 年7月收治的具有PRRT2基因突变的15例患儿的临床资料及基因检测结果。结果 15例患儿中男8例、女7例,中位起病 年龄6个月(4~13个月)。12例有发作性疾病家族史。13例患儿表现为局灶性发作或局灶性发作继发全面性发作; 1例表 现为痉挛发作; 1例在8月龄时出现癫痫发作,15岁时表现为发作性运动障碍。 2例患儿发作间期脑电图有癫痫样放电, 1 例呈不典型高度失律,12例未见异常。 3例患儿头颅MRI表现为额颞脑沟加深,12例未见异常。14例患儿应用抗癫痫药物 后控制良好,但其中1例停药后复发;另1例痉挛发作难以控制。15例患儿均发现PRRT2基因杂合突变, 9例为碱基重复突 变(c.649dupC,p.Arg217Profs*8),2例错义突变(c.439G>C,p.Asp147His;c.640G>C,p.Ala214Pro;c.962T>C,p.Leu321Pro), 2例碱基缺失突变(c.649delC,p.Arg217Glufs*12;c.650delG,p.Arg217Glnfs12*),2例无义突变(c.649C>T,p.Arg217*; c.970G>T,p.Gly324*),其中2个突变(c.962T>C,c.970G>T)为未曾报道的新突变。13例患儿的父母一方携带相同突变, 2例为新生突变。11例患儿诊断为良性家族性婴儿癫痫, 2例为良性婴儿癫痫, 1例为婴儿惊厥伴阵发性运动诱发的运动障 碍, 1例为婴儿痉挛。结论 PRRT2基因突变在儿科最常见的临床表型是良性家族性婴儿癫痫,其次为良性婴儿癫痫和婴 儿惊厥伴阵发性运动诱发的运动障碍等。c.649dupC是PRRT2基因的热点突变,c.962T>C、c.970G>T为未报道的可能致 病性突变。

关键词: 癫痫; PRRT2基因; 突变

Abstract: Objective To retrospectively analyze the clinical and genetic characteristics of PRRT2-associated paroxysmal diseases in children, and to improve the understanding of genotype-phenotype association of PRRT2 gene. Methods The clinical data and genetic results of 15 infant epilepsy or paroxysmal dyskinesia patients with PRRT2 mutations were collected from neurology department of Shanghai Children’s Medical Center between May 2016 to July 2018. Results A total of 15 patients including 8 males and 7 females were collected . The age at onset ranged from 3 months to 13 months and the median age of onset was 6 months. Thirteen patients presented focal seizures with or without secondary generalization, 1 patient presented infant spasms, and 1 patient had seizures at the age of 8 months and presented paroxysmal dyskinesia at the age of 15 years. Twelve patients had familial histories of paroxysmal diseases. Interictal electroencephalograms of 12 patients were normal, interictal electroencephalograms showed epileptiform discharges in 2 cases, atypical peak arrhythmias were observed in 1 patient. MRI tests were normal in 12 patients and showed deepen cerebral sulcus in 2 patients. Fourteen patients were well controlled after using antiepileptic drugs but 1 patient had recurrence after drug withdrawal, and 1 patient was resistant to antiepileptic drugs. All patients had PRRT2 heterozygous mutations, including 9 cases of duplication mutations (c.649dupC, p.Arg217Profs*8) , 2 cases of missense mutations (c.439G>C, p.Asp147His; c.640G>C, p.Ala214Pro; c.962T>C, p.Leu321Pro), 2 cases of deletion mutations (c.649delC, p.Arg217Glufs*12; c.650delG,p.Arg217Glnfs12*), 2 cases of nonsense mutation (c.649C>T, p.Arg217*; c.970G>T, p.Gly324*). Among these mutations, two were novel mutations (c.962T>C and c.970G>T). In 15 cases, 13 cases inherited mutations from one of parent, 2 cases were de novo mutation. Eleven patients were diagnosed as benign familial infant epilepsy (BFIE), 2 patients were diagnosed as benign infant epilepsy (BIE), 1 patient was diagnosed as paroxysmal kinesigenic dyskinesia with infantile convulsions (PKD/IC) and 1 patient was diagnosed as infant spasms. Conclusions The most common clinical phenotype of PRRT2 gene mutation in pediatrics is BFIE, followed by BIE and PKD/IC. C.649 dupC is the hotspot mutation of PRRT2 gene, and c.962T > C, c.970G > T are likely pathogenic mutations.

Key words:  epilepsy; PRRT2 gene; mutation